Patient Capital Management’s Herbalife HLF Stock Holding History

Patient Capital Management’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-194,300	Closed	-$5.9M	–	43
2022 Q1	$5.9M	Buy	194,300 +13,500	+7%	+$528K	2%	23
2021 Q4	$7.4M	Buy	+180,800	New	+$7.52M	2.13%	19

Other funds holding HLF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.49B AUM 10.92% 1-Year Est. Return

WPL

WINDACRE PARTNERSHIP LLC Houston, Texas $10.1B AUM 10.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACM

Alua Capital Management New York $103M AUM 11.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCM

Bronte Capital Management Bondi Junction, Australia $931M AUM 47.97% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Patient Capital Management's HLF Position: Q2 2022 in Review

Patient Capital Management sold out of Herbalife (HLF) in Q2 2022, closing a stake of 194,300 shares — an estimated $5.9M sold.

Patient Capital Management first reported a position in HLF in Q4 2021 and held it in 2 quarters. The position peaked at $7.4M in Q4 2021. 204 funds tracked by Wall St. Rank hold HLF as of Q2 2022.

Patient Capital Management reported no remaining Herbalife position as of Q2 2022 after selling out during the quarter.
Patient Capital Management sold 194,300 Herbalife shares in Q2 2022, an estimated $5.9M.
Patient Capital Management first reported a position in Herbalife in Q4 2021 and held it in 2 quarters.
Patient Capital Management's Herbalife position peaked at $7.4M in Q4 2021.
204 funds tracked by Wall St. Rank held Herbalife as of Q2 2022.

Based on Patient Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.